The DOI matches its Crossref record; 303 of the 303 references it cites were found in a registry or an index.
Nanoparticles and targeted drug delivery in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Positioning single atoms with a scanning tunnelling microscope
Eigler, D. M., & Schweizer, E. K. (1990) · Nature · doi:10.1038/344524a0 · Cited by 3,161
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Nicholson, R. I., Gee, J. M. W., & Harper, M. E. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,143
Liou, J.-C., Diao, C.-C., Lin, J.-J., Chen, Y.-L., & Yang, C.-F. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-1 · Cited by 2,068
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Transport properties of two finite armchair graphene nanoribbons
Rosales, L., & González, J. W. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-1 · Cited by 1,956
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Lewin, M., Carlesso, N., Tung, C.-H., Tang, X.-W., Cory, D., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Humphries, J. D., Byron, A., & Humphries, M. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03098 · Cited by 1,708
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Barczyk, M., Carracedo, S., & Gullberg, D. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0834-6 · Cited by 1,512
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,454
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
The convergence of synthetic organic and polymer chemistries
Hawker, C. J., & Wooley, K. L. (2005) · Science · doi:10.1126/science.1109778 · Cited by 1,298
Bioconjugated quantum dots for in vivo molecular and cellular imaging☆
SMITH, A., DUAN, H., MOHS, A., & NIE, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.015 · Cited by 1,193
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
(1989) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60215-8 · Cited by 1,087
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein
Elliott, G., & O'Hare, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81843-7 · Cited by 972
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Virus entry by macropinocytosis
Mercer, J., & Helenius, A. (2009) · Nature Cell Biology · doi:10.1038/ncb0509-510 · Cited by 816
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Cancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 702
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
The role of selectins in inflammation and disease
Ley, K. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00071-6 · Cited by 682
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 670
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Yu, M. K., Jeong, Y. Y., Park, J., Park, S., Kim, J. W., Min, J. J., Kim, K., & Jon, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800857 · Cited by 615
Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy
Kievit, F. M., & Zhang, M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000277 · Cited by 602
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Andrew MacKay, J., Chen, M., McDaniel, J. R., Liu, W., Simnick, A. J., & Chilkoti, A. (2009) · Nature Materials · doi:10.1038/nmat2569 · Cited by 580
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Kou, L., Sun, J., Zhai, Y., & He, Z. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.001 · Cited by 569
Nam, H. Y., Kwon, S. M., Chung, H., Lee, S.-Y., Kwon, S.-H., Jeon, H., Kim, Y., Park, J. H., Kim, J., Her, S., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.018 · Cited by 564
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
Li, L., Fang, C. J., Ryan, J. C., Niemi, E. C., Lebrón, J. A., Björkman, P. J., Arase, H., Torti, F. M., Torti, S. V., Nakamura, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913192107 · Cited by 561
Yuan, H., Fales, A. M., & Vo-Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 523
Nanoparticles in modern medicine: state of the art and future challenges.
(2007) · PubMed Central · Cited by 484
Koivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477
Affinity enhancement by multivalent lectin–carbohydrate interaction
Lee, R. T., & Lee, Y. C. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011070425430 · Cited by 469
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Dong, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 464
In Vivo Molecular Photoacoustic Tomography of Melanomas Targeted by Bioconjugated Gold Nanocages
Kim, C., Cho, E. C., Chen, J., Song, K. H., Au, L., Favazza, C., Zhang, Q., Cobley, C. M., Gao, F., Xia, Y., et al. (2010) · ACS Nano · doi:10.1021/nn100736c · Cited by 462
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449
EGFR Signaling and Drug Discovery
Lurje, G., & Lenz, H.-J. (2009) · Oncology · doi:10.1159/000279388 · Cited by 442
Polymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.006 · Cited by 436
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1247 · Cited by 432
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
The effect of surface functionality on cellular trafficking of dendrimers
Perumal, O. P., Inapagolla, R., Kannan, S., & Kannan, R. M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.038 · Cited by 379
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Jiang, T., Zhang, Z., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 359
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Tat Peptide as an Efficient Molecule To Translocate Gold Nanoparticles into the Cell Nucleus
de la Fuente, J. M., & Berry, C. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050033+ · Cited by 342
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.048 · Cited by 337
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Micellar Hybrid Nanoparticles for Simultaneous Magnetofluorescent Imaging and Drug Delivery
Park, J., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801810 · Cited by 333
Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor.
Haigler, H. T., McKanna, J. A., & Cohen, S. (1979) · The Journal of cell biology · doi:10.1083/jcb.83.1.82 · Cited by 330
The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn, J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080003 · Cited by 330
Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., & Bae, Y. H. (2008) · Small · doi:10.1002/smll.200701275 · Cited by 313
Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Hall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90048-9 · Cited by 293
Uptake mechanisms of non-viral gene delivery
Xiang, S., Tong, H., Shi, Q., Fernandes, J. C., Jin, T., Dai, K., & Zhang, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.093 · Cited by 284
Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications
BERG, K., SELBO, P. K., WEYERGANG, A., DIETZE, A., PRASMICKAITE, L., BONSTED, A., ENGESAETER, B. Ø., ANGELL‐PETERSEN, E., WARLOE, T., FRANDSEN, N., et al. (2005) · Journal of Microscopy · doi:10.1111/j.1365-2818.2005.01471.x · Cited by 274
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Zu (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12918 · Cited by 272
Sun, C., Du, K., Fang, C., Bhattarai, N., Veiseh, O., Kievit, F., Stephen, Z., Lee, D., Ellenbogen, R. G., Ratner, B., et al. (2010) · ACS Nano · doi:10.1021/nn100190v · Cited by 271
Cheng, Y., Dai, Q., Morshed, R. A., Fan, X., Wegscheid, M. L., Wainwright, D. A., Han, Y., Zhang, L., Auffinger, B., Tobias, A. L., et al. (2014) · Small · doi:10.1002/smll.201400654 · Cited by 271
Insights from transgenic mouse models of ERBB2-induced breast cancer
Ursini-Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2127 · Cited by 269
Lu, W., Zhang, G., Zhang, R., Flores, L. G., Huang, Q., Gelovani, J. G., & Li, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3379 · Cited by 266
Ma, Z., & Lim, L.-Y. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003379.76417.3e · Cited by 265
Dixit, S., Novak, T., Miller, K., Zhu, Y., Kenney, M. E., & Broome, A.-M. (2015) · Nanoscale · doi:10.1039/c4nr04853a · Cited by 262
Chen, X., Plasencia, C., Hou, Y., & Neamati, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049165z · Cited by 256
Tseng, Y.-L., Liu, J.-J., & Hong, R.-L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.864 · Cited by 241
Tumor Targeting via Integrin Ligands
Marelli, U. K., Rechenmacher, F., Sobahi, T. R. A., Mas-Moruno, C., & Kessler, H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00222 · Cited by 236
Xiao, Y., Hong, H., Javadi, A., Engle, J. W., Xu, W., Yang, Y., Zhang, Y., Barnhart, T. E., Cai, W., & Gong, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.030 · Cited by 234
Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Zheng, G., Chen, J., Li, H., & Glickson, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508677102 · Cited by 226
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
Zhang, B., Sun, X., Mei, H., Wang, Y., Liao, Z., Chen, J., Zhang, Q., Hu, Y., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.039 · Cited by 225
pH-triggered intracellular release from actively targeting polymer micelles
Guo, X., Shi, C., Wang, J., Di, S., & Zhou, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.071 · Cited by 225
Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells
Firestone, R. A. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00026a002 · Cited by 225
Important role of integrins in the cancer biology
Rathinam, R., & Alahari, S. K. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9211-x · Cited by 221
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.003 · Cited by 217
Peer, D., & Margalit, R. (2004) · Neoplasia · doi:10.1593/neo.03460 · Cited by 214
Dodd, C. H., Hsu, H.-C., Chu, W.-J., Yang, P., Zhang, H.-G., Mountz, J. D., Zinn, K., Forder, J., Josephson, L., Weissleder, R., et al. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00433-1 · Cited by 212
Cellular Uptake and Cytotoxicity of Silica Nanotubes
Nan, A., Bai, X., Son, S. J., Lee, S. B., & Ghandehari, H. (2008) · Nano Letters · doi:10.1021/nl0802741 · Cited by 212
Hu, C.-M. J., Kaushal, S., Cao, H. S. T., Aryal, S., Sartor, M., Esener, S., Bouvet, M., & Zhang, L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900316a · Cited by 212
Georgieva, J., Hoekstra, D., & Zuhorn, I. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6040557 · Cited by 211
Biocompatibility of transition metal-substituted cobalt ferrite nanoparticles
Sanpo, N., Tharajak, J., Li, Y., Berndt, C. C., Wen, C., & Wang, J. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2510-3 · Cited by 210
MRI-Visible Micellar Nanomedicine for Targeted Drug Delivery to Lung Cancer Cells
Guthi, J. S., Yang, S.-G., Huang, G., Li, S., Khemtong, C., Kessinger, C. W., Peyton, M., Minna, J. D., Brown, K. C., & Gao, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9001393 · Cited by 197
Malhotra, M., Tomaro-Duchesneau, C., & Prakash, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.013 · Cited by 192
Gupta, Y., Jain, A., & Jain, S. K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0004 · Cited by 192
Wang, F., Chen, L., Zhang, R., Chen, Z., & Zhu, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.012 · Cited by 190
Conserved Functions of Membrane Active GTPases in Coated Vesicle Formation
Pucadyil, T. J., & Schmid, S. L. (2009) · Science · doi:10.1126/science.1171004 · Cited by 186
Jadidi-Niaragh, F., Atyabi, F., Rastegari, A., Kheshtchin, N., Arab, S., Hassannia, H., Ajami, M., Mirsanei, Z., Habibi, S., Masoumi, F., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.012 · Cited by 183
Self-citationHan, L., Huang, R., Liu, S., Huang, S., & Jiang, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100185f · Cited by 182
Potassium permeability of single compartment liposomes with and without valinomycin
Johnson, S. M., & Bangham, A. D. (1969) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(69)90061-3 · Cited by 173
Focusing on clathrin-mediated endocytosis.
Rappoport, J. Z. (2008) · Biochemical Journal · doi:10.1042/bj20080474 · Cited by 172
Nikanjam, M., Gibbs, A. R., Hunt, C. A., Budinger, T. F., & Forte, T. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.007 · Cited by 165
Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 160
Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting
Tseng, C.-L., Wang, T.-W., Dong, G.-C., Yueh-Hsiu Wu, S., Young, T.-H., Shieh, M.-J., Lou, P.-J., & Lin, F.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.006 · Cited by 160
Li, J., Liu, F., Shao, Q., Min, Y., Costa, M., Yeow, E. K. L., & Xing, B. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300613 · Cited by 159
Expression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cells
Vogel, U., Sandvig, K., & Deurs, B. V. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.6.825 · Cited by 159
Rousselle, C., Smirnova, M., Clair, P., Lefauconnier, J.-M., Chavanieu, A., Calas, B., Scherrmann, J.-M., & Temsamani, J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29672-5 · Cited by 159
Yang, X., lyer, A. K., Singh, A., Choy, E., Hornicek, F. J., Amiji, M. M., & Duan, Z. (2015) · Scientific Reports · doi:10.1038/srep08509 · Cited by 158
Shen, H., Shi, S., Zhang, Z., Gong, T., & Sun, X. (2015) · Theranostics · doi:10.7150/thno.10804 · Cited by 158
pH-sensitive Liposomes for Drug Delivery in Cancer Treatment
Ferreira, D. D. S., Lopes, S. C. D. A., Franco, M. S., & Oliveira, M. C. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.80 · Cited by 158
Mansoori, G. A., Brandenburg, K. S., & Shakeri‐Zadeh, A. (2010) · Cancers · doi:10.3390/cancers2041911 · Cited by 157
Song, S., Liu, D., Peng, J., Deng, H., Guo, Y., Xu, L. X., Miller, A. D., & Xu, Y. (2009) · The FASEB Journal · doi:10.1096/fj.08-117002 · Cited by 157
Suk, J. S., Suh, J., Choy, K., Lai, S. K., Fu, J., & Hanes, J. S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.013 · Cited by 156
Zhang, J., Sun, H., & Ma, P. X. (2010) · ACS Nano · doi:10.1021/nn901213a · Cited by 155
Obaid, G., Chambrier, I., Cook, M. J., & Russell, D. A. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00312h · Cited by 151
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
Garg, A., Tisdale, A. W., Haidari, E. S., & Kokkoli, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.016 · Cited by 151
Tseng, C., Wu, S. Y.-H., Wang, W.-H., Peng, C., Lin, F., Lin, C.-C., Young, T., & Shieh, M.-J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.03.033 · Cited by 150
Tekle, C., van Deurs, B., Sandvig, K., & Iversen, T. (2008) · Nano Letters · doi:10.1021/nl0803848 · Cited by 150
Shao, Z., Shao, J., Tan, B., Guan, S., Liu, Z., Zhao, Z., He, F., & Zhao, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77837 · Cited by 148
Targeted Iron-Oxide Nanoparticle for Photodynamic Therapy and Imaging of Head and Neck Cancer
Wang, D., Fei, B., Halig, L. V., Qin, X., Hu, Z., Xu, H. T., Wang, Y. A., Chen, Z., Kim, S., Shin, D. M., et al. (2014) · ACS Nano · doi:10.1021/nn501652j · Cited by 147
In vivo biodistribution and efficacy of peptide mediated delivery
Järver, P., Mäger, I., & Langel, Ü. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.006 · Cited by 145
Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment
Shin, M. C., Zhang, J., Min, K. A., Lee, K., Byun, Y., David, A. E., He, H., & Yang, V. C.-M. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34859 · Cited by 144
Gao, Z.-G., Tian, L., Hu, J., Park, I.-S., & Bae, Y. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.021 · Cited by 144
Clathrin‐Coated Pits: Vive La Différence?
Benmerah, A., & Lamaze, C. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00585.x · Cited by 143
Applications of Nanoparticles for MRI Cancer Diagnosis and Therapy
Błasiak, B., van Veggel, F. C. J. M., & Tomanek, B. (2013) · Journal of Nanomaterials · doi:10.1155/2013/148578 · Cited by 140
Molecular structure of low density lipoprotein: current status and future challenges
Prassl, R., & Laggner, P. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0368-y · Cited by 139
Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 139
Design of a Tumor-Homing Cell-Penetrating Peptide
Myrberg, H., Zhang, L., Mäe, M. A., & Langel, Ü. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0701139 · Cited by 137
A Biodegradable pH-sensitive Micelle System for Targeting Acidic Solid Tumors
Sethuraman, V. A., Lee, M. C., & Bae, Y. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9480-4 · Cited by 135
Shevtsov, M. A., Nikolaev, B. P., Yakovleva, L. Y., Marchenko, Y., Михрина, А. Л., Martynova, M. G., Bystrova, O. A., Добродумов, А. В., Ischenko, A. M., & Yakovenko, I. V. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55118 · Cited by 132
Carbohydrate signals in metastasis and prognosis of human carcinomas
Muramatsu, T. (1993) · Glycobiology · doi:10.1093/glycob/3.4.291 · Cited by 131
Shen, Z., Li, Y., Kohama, K., O’Neill, B., & Bi, J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.10.012 · Cited by 127
Directed evolution of gold nanoparticle delivery to cells
Li, N., Larson, T. A., Nguyen, H. H., Sokolov, K., & Ellington, A. D. (2009) · Chemical Communications · doi:10.1039/b920865h · Cited by 126
Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy
Bahrami, B., Mohammadnia‐Afrouzi, M., Bakhshaei, P., Yazdani, Y., Ghalamfarsa, G., Yousefi, M., Sadreddini, S., Jadidi‐Niaragh, F., & Hojjat‐Farsangi, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-3706-6 · Cited by 121
Self-citationIntegrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
Eldar-Boock, A., Miller, K., Sanchis, J., Lupu, R., Vicent, M., & Satchi-Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.073 · Cited by 120
Morales-Ávila, E., Ferro‐Flores, G., Ocampo‐García, B., Rodriguez, L. M. D. L., Santos‐Cuevas, C., Garcı́a-Becerra, R., Medina, L. A., & Gómez‐Oliván, L. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100551s · Cited by 118
Self-Assembly of a Virus-Mimicking Nanostructure System for Efficient Tumor-Targeted Gene Delivery
Xu, L., Frederik, P. M., Pirollo, K. F., Tang, W., Rait, A. S., Xiang, L., Huang, W., Cruz, I., Yin, Y., & Chang, E. H. (2002) · Human Gene Therapy · doi:10.1089/10430340252792594 · Cited by 117
Protease‐Triggered Unveiling of Bioactive Nanoparticles
Harris, T. J., von Maltzahn, G., Lord, M. E., Park, J., Agrawal, A., Min, D., Sailor, M. J., & Bhatia, S. N. (2008) · Small · doi:10.1002/smll.200701319 · Cited by 117
Park, Y. J., Chang, L., Liang, J. F., Moon, C., Chung, C., & Yang, V. C.-M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2322fje · Cited by 116
The EGF receptor: structure, regulation and potential role in malignancy.
Thompson, D. M., & Gill, G. N. (1985) · PubMed · Cited by 116
García, M. L., Pérez, Y., Gomara, M. J., Vasconcelos, A., Vega, E., & Haro, I. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s71198 · Cited by 115
Guo, Y., Wang, L., Lv, P., & Zhang, P. (2014) · Oncology Letters · doi:10.3892/ol.2014.2840 · Cited by 114
A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo
Lehto, T., Simonson, O. E., Mäger, I., Ezzat, K., Sork, H., Copolovici, D. M., Viola, J. R., Zaghloul, E. M., Lundin, P., Moreno, P. M. D., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.10 · Cited by 114
Zhu, Q., Zhou, Y., Guan, M., Zhou, X., Yang, S.-D., Liu, Y., Chen, W.-L., Zhang, C.-G., Yuan, Z.-Q., Liu, C., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.088 · Cited by 113
Overview on experimental models of interactions between nanoparticles and the immune system
Najafi-Hajivar, S., Zakeri‐Milani, P., Mohammadi, H., Niazi, M., Soleymani-Goloujeh, M., Baradaran, B., & Valizadeh, H. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.060 · Cited by 113
Self-citationGuo, Z., He, B., Jin, H., Zhang, H., Dai, W., Zhang, L., Zhang, H., Wang, X., Wang, J., Zhang, X., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.031 · Cited by 112
Klutz, K., Schaffert, D., Willhauck, M. J., Grünwald, G. K., Haase, R., Wunderlich, N., Zach, C., Gildehaus, F. J., Senekowitsch–Schmidtke, R., Göke, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.296 · Cited by 109
Surface Functionalized Gold Nanoparticles for Drug Delivery
Cheng, J., Gu, Y., Cheng, S. H., & Wong, W. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1536 · Cited by 107
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery
Qin, Y., Chen, H., Yuan, W., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.021 · Cited by 103
Vilchis-Juárez, A., Ferro‐Flores, G., Santos‐Cuevas, C., Morales-Ávila, E., Ocampo‐García, B., Díaz, L., Luna‐Gutiérrez, M., Jiménez‐Mancilla, N., Pedraza-López, M., & Gómez‐Oliván, L. M. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1721 · Cited by 103
Winer, I. S., Wang, S., Lee, Y.-E. K., Fan, W., Gong, Y., Burgos-Ojeda, D., Spahlinger, G., Kopelman, R., & Buckanovich, R. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1917 · Cited by 102
Structure-Function Analysis of Arg-Gly-Asp Helix Motifs in αvβ6 Integrin Ligands
DiCara, D. M., Rapisarda, C., Sutcliffe-Goulden, J., Violette, S. M., Weinreb, P. H., Hart, I. R., Howard, M. J., & Marshall, J. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610461200 · Cited by 97
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
Arosio, D., Manzoni, L., Araldi, E. M. V., & Scolastico, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100448r · Cited by 96
Hao, H., Ma, Q., Huang, C., He, F., & Yao, P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.041 · Cited by 96
Transferrin receptor 2: a new molecule in iron metabolism
Trinder, D., & Baker, E. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00258-3 · Cited by 94
Porru, M., Zappavigna, S., Salzano, G., Luce, A., Stoppacciaro, A., Balestrieri, M. L., Artuso, S., Lusa, S., Rosa, G. D., Leonetti, C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2182 · Cited by 93
Koppu, S., Oh, Y. J., Edrada‐Ebel, R., Blatchford, D. R., Tetley, L., Tate, R. J., & Dufès, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.015 · Cited by 92
Harisa, G. I., & Alanazi, F. K. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.12.015 · Cited by 92
The scope of nanoparticle therapies for future metastatic melanoma treatment
Bombelli, F. B., Webster, C. A., Moncrieff, M. D., & Sherwood, V. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70333-4 · Cited by 92
Marra, M., Salzano, G., Leonetti, C., et al. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.06.018 · Cited by 91
Malarvizhi, G. L., Retnakumari, A. P., Nair, S. V., & Koyakutty, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.011 · Cited by 91
Yang, R., Tang, Q., An, Y., Miao, F., Liu, P., & Li, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67210 · Cited by 90
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors
Salzano, G., Marra, M., Porru, M., Zappavigna, S., Abbruzzese, A., Rotonda, M. I. L., Leonetti, C., Caraglia, M., & Rosa, G. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.046 · Cited by 89
Prabaharan, M., Grailer, J. J., Steeber, D. A., & Gong, S. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800366 · Cited by 89
RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy
Ji, S., Xu, J., Zhang, B., Yao, W., Xu, W., Wu, W., Xu, Y., Wang, H., Ni, Q., Hou, H., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.4.18692 · Cited by 89
Fu, H., Shi, K., Hu, G., Yang, Y., Kuang, Q., Lu, L., Zhang, L., Chen, W., Dong, M., Chen, Y., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24291 · Cited by 87
Cited by
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer
Singh, P., Pandit, S., Mokkapati, V. R. S. S., Garg, A., Ravikumar, V., & Mijakovic, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071979 · Cited by 1,038
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.035 · Cited by 349
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L., & Raut, C. P. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21498 · Cited by 338
Metadata
- Authors
- Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F.
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 190
- Pages
- 64-83
- ISSN
- 0165-2478 (ISSN-L)
- OpenAlex
- W2741312435
- Cited by
- 510
- References
- 303
- FWCI
- 15.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.